Live feed
Filing
SC 13D/A
SC 13D/A0000831547-19-000018·CASI Pharmaceuticals, Inc (DE)
Schedule 13D ownership disclosure
ENTREMED INC
Security class unavailable · CUSIP: 29382F202
Event date: 2019-04-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000831547-19-000018
- Form type
- SC 13D/A
- Filer
- CASI Pharmaceuticals, Inc (DE)
- CIK
- CIK 895051
- Filed
- Apr 11, 2019
- Reporting period
- Apr 02, 2019
- Description
- Schedule 13D beneficial ownership